St. Jude Children's Research Hospital: Targeting a Transporter to Treat SHH Medulloblastoma
April 01, 2020
April 01, 2020
MEMPHIS, Tennessee, April 1 -- St. Jude Children's Research Hospital issued the following news release:
Investigators at St. Jude Children's Research Hospital have found that the ABCC4 transporter is critical to the SHH signaling pathway in the brain tumor medulloblastoma. This work provides a rationale for development of small molecule inhibitors that target ABCC4. The findings appeared in Cancer Research.
Medulloblastoma is the most common malignant pediatric brain tu . . .
Investigators at St. Jude Children's Research Hospital have found that the ABCC4 transporter is critical to the SHH signaling pathway in the brain tumor medulloblastoma. This work provides a rationale for development of small molecule inhibitors that target ABCC4. The findings appeared in Cancer Research.
Medulloblastoma is the most common malignant pediatric brain tu . . .